1.
Kaustubh Bhardwaj, Himanshi Bhardwaj, Amit Tripathi, et al. FUTURE CHALLENGES AND EMERGING SAFETY CONCERNS OF GLP-1 RECEPTOR AGONISTS, DUAL INCRETIN AGONISTS, AND SGLT2 INHIBITORS. J Popl Ther Clin Pharmacol. 2026;33(2):963-981. doi:10.69980/mng8r305